Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of Petros Pharmaceuticals, Inc. to be filed on or about January 29, 2021 of our report dated May 16, 2020, on our audits of the consolidated financial statements of Metuchen Pharmaceuticals, LLC and Subsidiaries as of December 31, 2019 (Successor) and 2018 (Successor), and for the year ended December 31, 2019 (Successor), and each of the periods December 10, 2018 through December 31, 2018 (Successor), and January 1, 2018 through December 9, 2018 (Predecessor), which report is included in Petros Pharmaceuticals, Inc.’s joint proxy statement/prospectus on Form S-4 dated October 27, 2020 filed with the SEC on October 28, 2020. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern. We also consent to the reference to our firm under the caption “Experts” in this registration statement.
/s/EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
January 29, 2021
